OneTrust Debuts on Fortune's Future 50 List
2025 Fortune Future 50 list recognizes OneTrust for leadership in responsible use of data and AI
"AI will define the next decade of business, and governance will determine who succeeds," said
OneTrust serves more than 14,000 organizations globally, including over half of the Fortune 500. As enterprises race to adopt AI, OneTrust is the AI-ready governance platform they trust to innovate responsibly. With capabilities such as privacy and risk agents, Copilots, AI-driven workflows, and automated policy enforcement, the OneTrust platform enables teams to accelerate the governance lifecycle and drive lasting return on investment (ROI). The company also partners with global leaders––like Adobe, Databricks, Microsoft, and Snowflake–so organizations can ensure data and AI are used responsibly across their platforms of choice.
To identify the 2025 Future 50, Boston Consulting Group examined more than 2,800 publicly traded companies with at least
TrustWeek 2025
OneTrust is hosting its annual TrustWeek conference, covering trust, data, and responsible AI across several cities, including
About OneTrust
OneTrust is the leading AI-ready governance platform. More than 14,000 customers globally, including over half of the Fortune 500, rely on OneTrust to accelerate innovation while ensuring responsible data use. To learn more, follow OneTrust on LinkedIn or visit www.onetrust.com.
© 2025 OneTrust LLC. All rights reserved. OneTrust and the OneTrust logo are trademarks or registered trademarks of OneTrust LLC in
Media Contact
Ainslee Shea
[email protected]
+1 (404) 855-0803
View original content to download multimedia:https://www.prnewswire.com/news-releases/onetrust-debuts-on-fortunes-future-50-list-302556661.html
SOURCE OneTrust
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kreyco Calls for Independent Investigation into NYC Department of Education Contracting, Oversight, Student Protection, and Accountability Practices
- Innovent's Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second
- Silvercorp Announces Filing of Updated Technical Reports
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share